Interestingly, miR-29c-3p and two other dysregulated miRNAs target MDM2, an important regulator of the p53 signaling pathway and whose inhibition has gained increasing attention in the treatment of cancers and auto-immune disorders (47). Here, TP53 is linked to cancer.